Gilead shares fall after company misses on revenue

Gilead Sciences Inc.
GILD, +0.17%
shares fell 6% late Thursday after the Silicon Valley biotech company reported lower-than-expected first-quarter sales. Gilead said it earned an adjusted $4.3 billion, or $3.03 a share, in the quarter, compared with $4.6 billion, or $2.94 a share, in the year-ago period. Revenue reached $7.8 billion in the quarter, up from $7.6 billion a year ago. Analysts polled by FactSet had expected Gilead to report adjusted earnings of $3.15 a share on sales of $8.06 billion. In a separate statement, Gilead said it has declared a dividend of 47 cents a share for the second quarter, payable June 29 to shareholders of record June 16. Shares of Gilead had ended the regular trading day down 3.7%.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.